The naphthalene state of the science symposium: Objectives, organization, structure, and charge

Regulatory Toxicology and Pharmacology

Volumn 51, Issue 2 SUPLL, 2008, Pages 1-5

  Belzer, Richard B ^a   Bus, James S ^b   Cavalieri, Ercole L ^c   Lewis, Steven C ^d   North, D Warner ^e   Pleus, Richard C ^c  

^a Regulatory Checkbook   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e Stanford University   (United States)

Author keywords

Information quality; Naphthalene; Peer review; Peer review charge; Peer review objectives; Peer review organization; Peer review structure; Risk assessment

Indexed keywords

NAPHTHALENE;

ARTICLE; CHEMICAL STRUCTURE; DECISION MAKING; PEER REVIEW; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCIENTIFIC LITERATURE;

EID: 44649201446     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.10.017     Document Type: Article

References (22)

1. Abdo K.M., Grumbein S., Chou B.J., and Herbert R. Toxicity and carcinogenicity in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhalation Toxicol. 13 10 (2001) 931-950
2. Bogen K.T., Benson J.M., Clewell H.J., Dahl A.R., Krishnan K., Morris J.B., Omiecinski C.J., and Yost G.S. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S27-S36
3. Brusick D.J., Small M.S., Cavalieri E.L., Chakravarti D., Ding X., Longfellow D.G., Nakamura J., Rogan E.G., and Swenberg J.A. Possible genotoxic modes of action for naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S43-S50
4. Brusick D.J. A critical assessment of the genetic toxicity of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S37-S42
5. California Office of Human Health Hazard Assessment (OEHHA), 2004a. Long-term Health Effects of Exposure to Naphthalene. OEHHA, online at http://www.oehha.ca.gov/air/hot_spots/pdf/naphth080304.pdf.
6. California Office of Human Health Hazard Assessment (OEHHA), 2004b. Adoption of Unit Risk Value for Naphthalene. OEHHA, online at http://www.oehha.ca.gov/air/hot_spots/pdf/naphthmemo.pdf.
7. Environmental Protection Agency (EPA), 2000. Peer Review Handbook, second ed. EPA 100-B-00-001, Environmental Protection Agency.
8. Environmental Protection Agency (EPA), 2004. Toxicological Review of Naphthalene (CAS No. 91-20-3) In Support of Summary Information on the Integrated Risk Information System (IRIS). NCEA-S-1707, June 2004, External review draft. U.S. EPA Office of Research and Development, Washington, DC.
9. Environmental Protection Agency (EPA), 2005. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F.
10. Environmental Protection Agency (EPA), 2006. Peer Review Handbook, third ed. EPA/100/B-06/002.
11. Evans J.S., Gray G.M., Sielken R.L., Smith A.E., Valdez-Florez C., and Graham J.D. Use of probabilistic expert judgment in uncertainty analysis of carcinogenic potency. Regul. Toxicol. Pharmacol. 20 (1994) 15-36
12. Griego F.Y., Bogen K.T., Price P.S., and Weed D.L. Exposure, epidemiology and human cancer incidence of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S22-S26
13. International Agency for Research on Cancer (IARC), 2002. Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 82. IARC, Lyon, France.
14. National Research Council (NRC), 1983. Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
15. National Research Council (NRC), 1994. Science and Judgment in Risk Assessment. National Academy Press, Washington, DC.
16. National Research Council (NRC), 2006. Health Risks from Dioxin and Relate Compounds: Evaluation of the EPA Reassessment. Academy Press, Washington, DC.
17. National Toxicology Program (NTP), 2000. Toxicology and Carcinogenesis Study of Naphthalene in F344/N Rats (Inhalation Studies). Technical Report Series No. 500. National Toxicology Program, Research Triangle Park, NC.
18. North D.W., Abdo K.M., Benson J.M., Dahl A.R., Morris J.B., Renne R., and Witschi H. A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S6-S14
19. Office of Management and Budget (OMB), 1990. Current regulatory issues in risk assessment and risk management. In: Regulatory Program of the United States Government, April 1, 1990-March 31, 1991.
20. Office of Management and Budget (OMB), 2002. Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated by Federal Agencies; Notice; Republication. Fed. Reg. 67, 8452-8460.
21. Office of Management and Budget (OMB), 2005. Final Information Quality Bulletin for Peer Review. Fed. Reg. 70, 2664-2677.
22. Price P.S., and Jayjock M.A. Available data on naphthalene exposures: strenghts and limitations. Regul. Toxicol. Pharmacol. 51 Suppl. 1 (2008) S15-S21